Search research articles
Contact Us
Filters
Showing results (61-70 of 72) with videos related to
Page
of 8
Sort By:
Cancer Research
|
May 1, 1984
Biochemical and cellular effects of didemnins A and B
S L Crampton, E G Adams, S L Kuentzel, et al.
Cancer Research
|
March 15, 1993
Multidrug resistance is a component of V79 cell resistance to the alkylating agent adozelesin
B K Bhuyan, K S Smith, R C Kelly, et al.
Biochemical Pharmacology
|
December 1, 1971
Biochemical and pharmacologic studies with 1- -D-arabinofuranosylcytosine 5'-adamantoate (NSC-117614), a depot form of cytarabine
G L Neil, H H Buskirk, T E Moxley, et al.
Mutagenesis
|
November 1, 1986
Genotoxicity of the antitumor antibiotic CC-1065
P R Harbach, R J Trzos, J H Mazurek, et al.
British Journal of Cancer
|
September 1, 1990
P388 leukaemia cells resistant to the anthracycline menogaril lack multidrug resistant phenotype
G J Badiner, B C Moy, K S Smith, et al.
Selective Cancer Therapeutics
|
January 1, 1990
HPLC and flow cytometric analyses of uptake of adriamycin and menogaril by monolayers and multicell spheroids
T J Bichay, E G Adams, W R Inch, et al.
Cancer Chemotherapy and Pharmacology
|
January 1, 1992
Adozelesin, a potent new alkylating agent: cell-killing kinetics and cell-cycle effects
B K Bhuyan, K S Smith, E G Adams, et al.
Cancer Chemotherapy and Pharmacology
|
January 1, 1994
V79 Chinese hamster lung cells resistant to the bis-alkylator bizelesin are multidrug-resistant
R K Butryn, K S Smith, E G Adams, et al.
Cancer Research
|
November 1, 1983
Comparative genotoxicity of adriamycin and menogarol, two anthracycline antitumor agents
B K Bhuyan, D M Zimmer, J H Mazurek, et al.
Cancer Communications
|
February 1, 1991
Cytotoxicity of tetraplatin and cisplatin for human and rodent cell lines cultured as monolayers and multicellular spheroids
B K Bhuyan, S J Folz, J DeZwaan, et al.
Page
of 8
Search research articles
Search
Showing results (61-70 of 72) with videos related to
Sort By:
Page
of 8
Cancer Research
|
May 1, 1984
Biochemical and cellular effects of didemnins A and B
S L Crampton, E G Adams, S L Kuentzel, et al.
Cancer Research
|
March 15, 1993
Multidrug resistance is a component of V79 cell resistance to the alkylating agent adozelesin
B K Bhuyan, K S Smith, R C Kelly, et al.
Biochemical Pharmacology
|
December 1, 1971
Biochemical and pharmacologic studies with 1- -D-arabinofuranosylcytosine 5'-adamantoate (NSC-117614), a depot form of cytarabine
G L Neil, H H Buskirk, T E Moxley, et al.
Mutagenesis
|
November 1, 1986
Genotoxicity of the antitumor antibiotic CC-1065
P R Harbach, R J Trzos, J H Mazurek, et al.
British Journal of Cancer
|
September 1, 1990
P388 leukaemia cells resistant to the anthracycline menogaril lack multidrug resistant phenotype
G J Badiner, B C Moy, K S Smith, et al.
Selective Cancer Therapeutics
|
January 1, 1990
HPLC and flow cytometric analyses of uptake of adriamycin and menogaril by monolayers and multicell spheroids
T J Bichay, E G Adams, W R Inch, et al.
Cancer Chemotherapy and Pharmacology
|
January 1, 1992
Adozelesin, a potent new alkylating agent: cell-killing kinetics and cell-cycle effects
B K Bhuyan, K S Smith, E G Adams, et al.
Cancer Chemotherapy and Pharmacology
|
January 1, 1994
V79 Chinese hamster lung cells resistant to the bis-alkylator bizelesin are multidrug-resistant
R K Butryn, K S Smith, E G Adams, et al.
Cancer Research
|
November 1, 1983
Comparative genotoxicity of adriamycin and menogarol, two anthracycline antitumor agents
B K Bhuyan, D M Zimmer, J H Mazurek, et al.
Cancer Communications
|
February 1, 1991
Cytotoxicity of tetraplatin and cisplatin for human and rodent cell lines cultured as monolayers and multicellular spheroids
B K Bhuyan, S J Folz, J DeZwaan, et al.
Page
of 8